Ikaria Inc. to Present at 27th Annual JPMorgan Healthcare Conference
1/8/2009 9:45:39 AM
More...
|
Ikaria Inc. Named Private Company of the Year by New Jersey Technology Council
11/21/2008 12:09:11 PM
More...
|
Ikaria Inc. Strengthens Executive Leadership Team
10/3/2008 9:55:46 AM
More...
|
Ikaria Inc. Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics, LLC
9/2/2008 10:08:26 AM
More...
|
Ikaria Inc. Strengthens Commercial Operations and Human Resources Leadership
8/25/2008 8:37:38 AM
More...
|
Ikaria Inc.'s INOflo (Nitric Oxide) for Inhalation Approved in Japan
7/21/2008 6:53:02 AM
More...
|
Ikaria Inc. Strengthens Research & Development Team Appoints Dr. Deborah Petrowsky Vice President of Medical Affairs and Dr. Steven Knapp Vice President of Regulatory Affairs
7/1/2008 8:51:54 AM
More...
|
Ikaria Inc. Introduces Dr. Michael Cooreman as Vice President of Translational Medicine
6/25/2008 9:35:50 AM
More...
|
Ikaria Inc.'s INOflo (Nitric Oxide) for Inhalation to be Officially Approved in Japan
6/18/2008 8:19:45 AM
More...
|
Ikaria Inc. Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
5/19/2008 9:49:54 AM
More...
|
|